샘플 요청 목록

 카트 문의
시장보고서
상품코드
1786412

세계의 당뇨병 케어용 디바이스 시장

Diabetes Care Devices
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 282 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 당뇨병 케어용 디바이스 시장은 2030년까지 869억 달러에 달할 전망

2024년에 482억 달러로 추정되는 세계의 당뇨병 케어용 디바이스 시장은 분석 기간인 2024-2030년에 CAGR 10.3%로 성장하며, 2030년에는 869억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 혈당 모니터링 디바이스는 CAGR 12.5%를 기록하며, 분석 기간 종료시에는 511억 달러에 달할 것으로 예측됩니다. 인슐린 전달 디바이스 부문의 성장률은 분석 기간 중 CAGR 7.7%로 추정됩니다.

미국 시장은 131억 달러로 추정, 중국은 CAGR 14.4%로 성장 예측

미국의 당뇨병 케어용 디바이스 시장은 2024년에 131억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 182억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 14.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 7.2%와 9.2%로 예측됩니다. 유럽에서는 독일이 CAGR 약 8.2%로 성장할 것으로 예측됩니다.

세계 당뇨병 치료 기기 시장 - 주요 동향 및 촉진요인 요약

당뇨병 관리 기기의 발전이 환자 예후를 어떻게 개선하고 있는가?

당뇨병 관리 기기 시장은 질병 모니터링, 관리 및 치료 순응도를 향상시키는 기술 혁신으로 인해 혁명적인 변화를 겪고 있습니다. 연속 혈당 모니터링(CGM) 시스템의 개발은 혈당 수치 변동에 대한 실시간 인사이트를 제공하고, 기존의 핑거스틱 검사에 대한 의존도를 줄임으로써 게임 체인저가 되고 있습니다. 또한 스마트 인슐린 펜이나 폐쇄형 인슐린 펌프와 같은 인슐린 전달 시스템은 당뇨병 관리를 보다 정확하고 편리하게 만들어 줍니다. 디지털 헬스 통합의 부상으로 원격 모니터링 기능이 더욱 강화되어 의료 서비스 프로바이더는 실시간 데이터를 기반으로 치료 계획을 개인화할 수 있게 되었습니다. 또한 전 세계 당뇨병 유병률 증가, 특히 개발도상국에서의 당뇨병 유병률 증가는 합리적인 가격의 사용하기 쉬운 당뇨병 관리 기기에 대한 수요를 촉진하고 있습니다. 기업은 현재 환자들에게 보다 친숙하고 불편함 없는 기기를 구현하기 위해 소형화 및 비침습적 기술에 집중하고 있습니다.

당뇨병 관리를 바꾸는 획기적인 혁신이란?

당뇨병 관리 기기의 최신 혁신의 물결은 자동화, AI 기반 분석, 비침습적 모니터링에 집중되어 있습니다. 지속적인 혈당 측정에 따라 인슐린 투여량을 자동으로 조절하는 인공 췌장 시스템은 당뇨병 관리에 혁명을 일으키고 있습니다. 웨어러블 센서와 내장형 센서는 기존 CGM을 대체할 수 있는 유망 대안으로 떠오르고 있으며, 정확도 향상과 착용 시간 연장을 실현하고 있습니다. 마이크로니들 기술을 이용한 스마트 패치도 통증 없는 포도당 모니터링으로 인기를 끌고 있습니다. 또 다른 주요 발전은 AI 기반 예측 분석의 통합으로, 패턴을 감지하고 포도당 변동을 사전에 예측하는 데 도움이 될 수 있습니다. 또한 바이오센서 기술의 발전은 침습적 채혈의 필요성을 없애고, 땀과 눈물을 통한 포도당 모니터링의 길을 열어주고 있습니다. 이러한 기술 혁신으로 당뇨병 관리의 효율성이 높아지고 환자들의 부담도 줄어들고 있습니다.

디지털 헬스는 당뇨병 치료 생태계를 어떻게 재구성하고 있는가?

모바일 앱, 클라우드 기반 플랫폼, 원격의료를 포함한 디지털 헬스 솔루션의 통합은 당뇨병 관리에 혁명을 일으키고 있습니다. 스마트폰로 연결된 포도당 모니터를 통해 사용자는 측정값을 추적하고, 실시간 알림을 받고, 의료진과 원활하게 데이터를 공유할 수 있습니다. 또한 AI를 활용한 당뇨 코칭 앱의 보급으로 환자에게 개인화된 식단과 생활습관을 추천할 수 있게 되었습니다. 원격 환자 모니터링 프로그램의 등장은 특히 내분비내과 전문의에 대한 접근성이 제한되어 있는 소외된 지역에서 만성질환 관리를 더욱 강화시키고 있습니다. 보험사와 고용주들도 사전 예방적 치료를 촉진하는 디지털 툴을 통합한 당뇨병 관리 프로그램을 점점 더 많이 채택하고 있습니다. 이러한 개발로 인해 환자 참여와 장기적인 질병 관리가 크게 향상되었습니다.

당뇨병 관리 기기 시장 확대의 주요 촉진요인은 무엇인가?

당뇨병 관리 기기 시장의 성장은 당뇨병 유병률 증가, 저침습적 모니터링 솔루션에 대한 수요 증가, 디지털 헬스 기술 채택 확대 등 여러 가지 요인에 의해 이루어지고 있습니다. 인공 췌장 시스템 및 첨단 인슐린 전달 장치의 확장은 환자의 예후를 크게 개선하고 시장 성장을 가속하고 있습니다. 또한 바이오센서 기술의 지속적인 혁신은 포도당 모니터링을 더욱 정확하고 사용자 친화적으로 만들고 있습니다. 당뇨병 관리에서 AI의 보급 확대는 합병증 예측과 예방에 매우 중요한 역할을 하고 있습니다. 또한 당뇨병에 대한 인식을 높이고 치료 접근성을 개선하기 위한 정부의 구상은 시장 확대를 더욱 가속화하고 있습니다. 웨어러블 헬스 기술과 원격의료 솔루션의 급속한 보급은 질병 모니터링과 치료 순응도를 향상시키고 더 많은 성장을 가속하고 있습니다. 지속적인 기술 발전과 환자 중심의 접근 방식이 증가함에 따라 당뇨병 관리 기기 시장은 향후 수년간 지속적으로 확대될 것으로 예측됩니다.

부문

제품 유형(혈당 모니터링 디바이스, 인슐린 전달 디바이스), 최종 용도(병원, 외래 수술 센터, 진단 센터, 홈케어, 기타)

조사 대상 기업의 예

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • DarioHealth Corp.
  • Dexcom, Inc.
  • Diabeloop SA
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • GlucoMe
  • iHealth Labs, Inc.
  • Integrated Diabetes Services, LLC
  • Medtronic Plc
  • Novo Nordisk A/S
  • Prodigy Diabetes Care, LLC
  • Tandem Diabetes Care, Inc.
  • Trividia Health, Inc.
  • Ypsomed AG

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.19

Global Diabetes Care Devices Market to Reach US$86.9 Billion by 2030

The global market for Diabetes Care Devices estimated at US$48.2 Billion in the year 2024, is expected to reach US$86.9 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$51.1 Billion by the end of the analysis period. Growth in the Insulin Delivery Devices segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.1 Billion While China is Forecast to Grow at 14.4% CAGR

The Diabetes Care Devices market in the U.S. is estimated at US$13.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$18.2 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Diabetes Care Devices Market - Key Trends & Drivers Summarized

How Are Advancements in Diabetes Care Devices Enhancing Patient Outcomes?

The diabetes care devices market is undergoing a revolutionary shift, driven by technological innovations that are improving disease monitoring, management, and treatment adherence. The development of continuous glucose monitoring (CGM) systems has been a game-changer, providing real-time insights into blood sugar fluctuations and reducing dependence on traditional fingerstick testing. Additionally, insulin delivery systems, such as smart insulin pens and closed-loop insulin pumps, are making diabetes management more precise and convenient. The rise of digital health integration has further enhanced remote monitoring capabilities, allowing healthcare providers to personalize treatment plans based on real-time data. Moreover, the increasing prevalence of diabetes worldwide, particularly in developing regions, has spurred the demand for affordable and user-friendly diabetes care devices. Companies are now focusing on miniaturization and non-invasive technologies to make devices more accessible and less cumbersome for patients.

What Are the Breakthrough Innovations Transforming Diabetes Management?

The latest wave of innovations in diabetes care devices is centered around automation, AI-driven analytics, and non-invasive monitoring. Artificial pancreas systems, which automatically adjust insulin delivery based on continuous glucose readings, are revolutionizing diabetes control. Wearable and implantable sensors are emerging as promising alternatives to traditional CGMs, offering improved accuracy and longer wear durations. Smart patches with microneedle technology are also gaining traction for pain-free glucose monitoring. Another key development is the integration of AI-driven predictive analytics, which helps detect patterns and anticipate glucose fluctuations before they occur. Additionally, advances in biosensor technology are paving the way for glucose monitoring through sweat and tears, eliminating the need for invasive blood sampling. With these innovations, diabetes management is becoming more efficient and less intrusive for patients.

How Is Digital Health Reshaping the Diabetes Care Ecosystem?

The integration of digital health solutions, including mobile apps, cloud-based platforms, and telemedicine, is revolutionizing diabetes management. Smartphone-connected glucose monitors allow users to track their readings, receive real-time alerts, and share data with healthcare providers seamlessly. The proliferation of AI-driven diabetes coaching apps is also empowering patients with personalized dietary and lifestyle recommendations. The rise of remote patient monitoring programs has further strengthened chronic disease management, especially in underserved regions where access to endocrinologists is limited. Insurance companies and employers are also increasingly adopting diabetes management programs that integrate digital tools to promote proactive care. These developments are significantly enhancing patient engagement and long-term disease control.

What Are the Key Drivers Behind the Expansion of the Diabetes Care Devices Market?

The growth in the diabetes care devices market is driven by several factors, including rising diabetes prevalence, growing demand for minimally invasive monitoring solutions, and increasing adoption of digital health technologies. The expansion of artificial pancreas systems and advanced insulin delivery devices is significantly improving patient outcomes, fueling market growth. Additionally, continuous innovations in biosensor technology are making glucose monitoring more accurate and user-friendly. The increasing penetration of AI in diabetes management is also playing a pivotal role in predicting and preventing complications. Moreover, government initiatives to promote diabetes awareness and improve access to care are further accelerating market expansion. The rapid uptake of wearable health technologies and telehealth solutions is enhancing disease monitoring and treatment adherence, propelling further growth. With the ongoing technological advancements and growing patient-centric approaches, the diabetes care devices market is expected to witness sustained expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Diabetes Care Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices); End-Use (Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • DarioHealth Corp.
  • Dexcom, Inc.
  • Diabeloop SA
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • GlucoMe
  • iHealth Labs, Inc.
  • Integrated Diabetes Services, LLC
  • Medtronic Plc
  • Novo Nordisk A/S
  • Prodigy Diabetes Care, LLC
  • Tandem Diabetes Care, Inc.
  • Trividia Health, Inc.
  • Ypsomed AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Diabetes Care Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Diabetes Prevalence Throws the Spotlight on Technology-Driven Diabetes Care Devices
    • Shift Toward Personalized, Data-Driven Disease Management Spurs Demand for Smart Glucose Monitoring Systems
    • Rapid Adoption of Continuous Glucose Monitoring (CGM) Devices Strengthens the Business Case for Non-Invasive Solutions
    • Integration of Diabetes Devices with Smartphones and Wearables Enhances Real-Time Data Sharing and Engagement
    • Growth in Closed-Loop Systems and Artificial Pancreas Devices Accelerates Innovation in Insulin Delivery
    • Increased Use of Connected Insulin Pens and Smart Dose Calculators Promotes Adherence and Accuracy
    • Demand for Minimally Invasive and Painless Monitoring Technologies Drives Market Differentiation
    • Government Initiatives for Diabetes Prevention and Management Support Widespread Device Reimbursement
    • Rising Incidence of Type 1 Diabetes in Children Fuels Demand for Pediatric-Friendly Monitoring Systems
    • Digital Therapeutics and Remote Patient Monitoring Platforms Enhance Device Interoperability
    • Expansion of At-Home Testing and DTC Models Broadens Access to Personalized Diabetes Tools
    • Growing Popularity of Subscription Models and Integrated Care Platforms Drives Device Retention
    • Clinical Preference for Integrated Data Platforms Supports Multi-Device Ecosystem Development
    • AI-Driven Insights and Predictive Analytics Expand the Role of Devices in Proactive Disease Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Diabetes Care Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Diabetes Care Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Insulin Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Insulin Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Insulin Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Diabetes Care Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Diabetes Care Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Diabetes Care Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Diabetes Care Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제